Acquisition History / Altaris, LLC / Simulations Plus, Inc.
Altaris, LLC Acquires Simulations Plus, Inc.
Announced June 16, 2026 — $375M
What happened
Simulations Plus provides model-informed and AI-accelerated drug development software and services. It agreed on June 16, 2026 to be acquired by affiliates of healthcare investor Altaris for $18.50 per share in cash, approximately $375M and a 26% premium to the 60-day VWAP.
- Acquirer
- Altaris, LLC
- Target
- Simulations Plus, Inc.
- Announced
- June 16, 2026
- Price
- $375M
- Industry
- Drug development modeling software
- Buyer type
- Private equity
- Backing investors
- Altaris
- Status
- Announced, not yet closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Altaris, LLC acquire Simulations Plus, Inc.?
Altaris, LLC acquired Simulations Plus, Inc. on June 16, 2026. This was Altaris, LLC's 1st publicly tracked acquisition out of 1 we have on record.
How much did Altaris, LLC pay for Simulations Plus, Inc.?
Altaris, LLC paid $375M for Simulations Plus, Inc..
What does Simulations Plus, Inc. do?
Simulations Plus provides model-informed and AI-accelerated drug development software and services. It agreed on June 16, 2026 to be acquired by affiliates of healthcare investor Altaris for $18.50 per share in cash, approximately $375M and a 26% premium to the 60-day VWAP.
What other Drug development modeling software companies has Altaris, LLC acquired?
Simulations Plus, Inc. is Altaris, LLC's only publicly tracked acquisition in Drug development modeling software so far.